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Osteoblast differentiation from mesenchymal cells is regulated by multiple signalling path-
ways. Here we have analysed the roles of Fibroblast Growth Factor (FGF) and canonical
Wingless-type MMTV integration site (Wnt/β-Catenin) signalling pathways on zebrafish
osteogenesis. We have used transgenic and chemical interference approaches to manipu-
late these pathways and have found that both pathways are required for osteoblast differen-
tiation in vivo. Our analysis of bone markers suggests that these pathways act at the same
stage of differentiation to initiate expression of the osteoblast master regulatory gene osterix
(osx). We use two independent approaches that suggest that osx is a direct target of these
pathways. Firstly, we manipulate signalling and show that osx gene expression responds
with similar kinetics to that of known transcriptional targets of the FGF andWnt pathways.
Secondly, we have performed ChIP with transcription factors for both pathways and our
data suggest that a genomic region in the first intron of osxmediates transcriptional activa-
tion. Based upon these data, we propose that FGF andWnt/β-Catenin pathways act in part
by directing transcription of osx to promote osteoblast differentiation at sites of bone
formation.
Introduction
The bony skeleton initially develops in one of two ways, either by ossification of a cartilage
template (chondral ossification) or in the absence of a cartilage template (achondal ossifica-
tion). Osteoblasts (specialised cells that synthesise bone) are derived from multipotent mesen-
chymal stem cells which are found in different tissues. During chondral bone development,
osteoblasts initially differentiate in the perichondrium (a tissue which surrounds the cartilage),
and in achondral bone development osteoblasts differentiate in mesenchymal cell condensa-
tions. Later on in development and in adults, osteoblast progenitors are found in the bone mar-
row as well as in the periosteum (a tissue which surrounds bone). Genetic analysis in mice has
identified two transcription factors, Runx2 (Runt-related transcription factor 2) and Osx (also
known as Sp7), that act in a transcriptional cascade during osteoblast differentiation. In mice
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lacking either gene osteoblasts throughout the body fail to differentiate while other cell types
are largely unaffected[1–3]. In osteoblast progenitors, Runx2 expression precedes that of Osx
and it is known that Runx2 is required to activate Osx transcription[4]. Both transcription fac-
tors have been shown to activate expression of many markers of mature osteoblasts including
Collagen 1(Col1), Secreted protein acidic cysteine-rich (SPARC), Osteopontin (Opn), Bone Sialo-
protein (BSP), Osteocalcin (Osc) and Alkaline phosphatase (ALP)[5,6]. Whether Osx also plays
a pivotal role in osteoblastogenesis in humans is unclear as one study suggests a relatively mild
skeletal phenotype occurs when OSX is mutated[7].
FGF signalling plays a crucial role during skeletal development. Mutations in human
FGFR1, FGFR2, FGFR3, FGF10 and FGF23 all cause skeletal defects consistent with a role in
osteoblast differentiation and/or function[8]. However, experiments to define the role of the
FGF pathway in osteoblastogenesis have often generated conflicting results (reviewed in [9]
and [5]). For example it has been shown that FGF signalling activates expression of Runx2 in
MSCs to initiate the osteoblast lineage, and later activates Opn and BSP expression in maturing
osteoblasts [10–14]. This is supported by in vivo studies that have shown that mutations that
impair FGF sigalling reduced bone density [15–17]. On the other hand, activation of FGF sig-
nalling in vitro results in reduced expression of ALP and Col1 and induces osteoblast apoptosis
[18–20]. These results suggest that FGF signalling may play different roles during osteoblast
differentiation and that timing and strength of the FGF signal is crucial in these outcomes.
Wnt signalling via the β-Catenin pathway has more recently been identified as a key regula-
tor of osteoblastogenesis [21–23]. As with FGF signalling, a consensus has not emerged regard-
ing the precise role of the Wnt/β-Catenin pathway. Conditional inactivation of β-Catenin in
the murine embryo has established that it is required for Osx, Osc and Col1 expression in the
osteoblast lineage [24–27]. However, β-Catenin knock-out also causes an increase in the
expression of Runx2 and expression of a constitutively active form of β-Catenin blocks entry
into the osteoblast lineage. Together these results suggest that Wnt/β-Catenin acts at two
sequential stages, to inhibit differentiation initially, then to promote differentiation after com-
mitment. Other studies using murine MSCs have found that Wnt3a treatment upregulates
ALP, but does not affect Runx2, Osc or Col1 levels[28,29]. Further studies have shown that
Wnt/β-Catenin signalling promotes early osteoblastogenesis in vivo and in mouse embryonic
fibroblasts by direct activation of Runx2 expression [30,31]. Studies using human MSCs have
found that Wnt/β-Catenin acts to suppress entry into the osteoblast lineage [32–34] and analy-
sis ofWnt10b-/- mice suggests that an osteopenic phenotype results from decreased mainte-
nance of adult MSC in bone [35]. The finding that Osx and Wnts interract in positive and
negative regulatory loops may explain why it has been very difficult to ascribe a simple role for
Wnts in skeletal development [36,37]. Together these studies indicate that role of Wnt/β-Cate-
nin signalling varies according to the precise timing and context of the signalling event.
Analysis of zebrafish bone development suggests that the regulation of osteoblastogenesis
is conserved between fish and mammals. As in mammals, the retinoic acid, BMP and Hedge-
hog pathways regulate recruitment and/or anabolic activity of osteoblasts in zebrafish [38–
41]. Expression of runx2 (runx2a and runx2b), osx, col1a2, sparc, osc and opnmark progres-
sion of osteoblastogenesis [40,42–46]. Reporter transgenes based upon osx genomic sequence
have been generated in both zebrafish and medaka[46,47]. Both achondral and chondral skel-
etal development takes place in zebrafish, and although bone is cellular, bone marrow does
not form [48–50]. Here we analyse the roles that FGF andWnt/β-Catenin pathways play dur-
ing achondral ossification in the head. We find that both pathways promote ossification and
act at the level of osx expression. Besides acting in parallel to regulate osx expression, we also
find evidence that Wnt/β-Catenin signalling regulates the activity of the FGF pathway during
skeletogenesis.
FGF andWNT Regulate Osteoblast Differentiation
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Materials and Methods
All methods were performed using standardised protocols[51]. All animal husbandry and
experimentation was carried out under the supervision and approval of the Home Office (UK)
and the University of Sheffield Ethics Board. Adult zebrafish were maintained with a 14 h
light/10 h dark cycle at 28°C according to standard protocols and were mated using pair mating
in individual cross tanks. To kill fish, larvae were anesthetized with 0.2 mg/ml of Tricane at
4°C. Unless otherwise stated, 10 larvae were analysed for each sample after chemical treatment
or heat shock and representative images were chosen for figure panels.
Alizarin Red staining
Larvae were fixed 2 hours (hrs) in 4% formaldehyde/PBS, stored in 80%MeOH/H2O for 1
hour. The larvae were rinsed briefly in H2O with 0.1% Tween-20 (H2Otw). Then larvae were
bleached in 1.5% H2O2 in 1% KOH for 30 minutes at 37C. Larvae were stained in 1% KOH
with 0.04 mg/ml Alizarin red for 2 hrs. Larvae were passed through a glycerol series (25%, 50%,
80% glycerol in H2Otw) 10 minutes each and then photographed in 80% glycerol/H2O.
Alcian Blue staining
Larvae were fixed as above then stained in 0.1% Alcian Blue in 0.1N HCl overnight and
bleached as above. The staining was fixed for 10 minutes in borate buffer (30% saturated-
sodium tetraborate in H2Otw), and then cleared with trypsin (0.5mg/ml trypsin in borate
buffer) until the tissue was completely digested away from the skeleton (2–3 hrs at 37°C). Lar-
vae were then photographed in glycerol as above. Larvae stained this way can be stored
indefinitely.
von Kossa staining
Larvae fixed at 120hpf for 2 hrs in 4%PFA were rinsed 3X 5min in H2Otw. Then larvae were
incubated for 45–60 minutes in 1% aqueous silver nitrate under incandescent lamp (60W) and
staining was monitored at regular time intervals. Following 3X 5min H2Otw rinses larvae were
then fixed in 2.5% sodium thiosulfate for 10 minutes and post-fixed in 4%PFA for 30 minutes.
Larvae were then photographed in glycerol as above. Larvae stained this way can be stored
indefinitely.
Heat shock procedure
20–40 larvae were placed in 25ml E3 buffer in a 50ml falcon tube and put into a water bath at
38°C for one hr. Heat shock time refers to the start of the heat shock. Continuous transgenic
expression was accomplished by heat shocking for one hour every 12 hours for the duration of
the treatment. All experiments were done with hemizygous carriers and included the wild type
siblings as controls, larvae were sorted after heat shock based upon fluorescence of the
transgene.
Chemical treatments
SU5402 (Merck) was made up in DMSO to 10mM and stored at -20°C. GSK-3 Inhibitor XV
(Merck) was made up in DMSO to 5mM and stored at -20°C. All treatments were done at a
dilution of 10uM in E3 in the dark.
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Time courses and qPCR
For FGF signalling, three batches of 15 wild type embryos were treated with SU5402 at 50hpf
(2hrs), 50.5hpf(1.5hrs), 51hpf(1hr) and 51.5hpf(0.5hr). All treatments and an untreated batch
were terminated at 52hpf and processed using Trizol and Superscript II following the manufac-
turer's protocols (Invitrogen). qPCR was performed using iQ SYBR Green Supermix (Bio-Rad)
with a Bio-Rad MyiQ system. Primer pairs for pea3 and osx performed equivalently in a dilu-
tion series so the comparative CT method was used to calculate relative expression levels. For
Wnt/β-Catenin signalling, hs:dkk1 hemizygous fish were crossed to Tg(TOP:GFP) homozygous
carriers. The offspring were heat shocked at 48hpf and sorted based upon fluorescence. Three
batches of fifteen hs:dkk1and fifteen sibling fish were fixed every two hours until 54hpf. RNA
was processed using Ultraspec (AMS Biotechnology) and the High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems) using manufacturers' protocols. Input levels were
quantified using TaqMan probes, and Universal Mastermix and ABI 7200 (Applied Biosys-
tems). The housekeeping gene phosphoglycerate kinase 1 (pgk1) was used to normalise. Non-
heatshocked fish at 48hpf (unsorted) were also processed as a control. Significance was tested
using the Students T-test using three technical replicates and comparison of the individual
dCT values. Primer sequences are listed in S1 Table.
Chromatin Immunoprecipitation (ChIP)
100 embryos were first deyolked using 1ml deyolking buffer and vortexed at 1000rpm for 5
minutes, cross-linked in 1ml fresh 1% formaldehyde for 15 minutes at room temperature and
washed 3 times with 0.125M Glycine and 2 times with cold PBS. DNA was extracted by adding
600μl DNA extraction buffer (containing protease inhibitors), mixed 20 times with a 200μl tip
and incubated on a shaker for 1 to 2 hours at 4°C. After centrifugation for 5 minutes at
3500rpm (4°C), the pellet was dissolved in 400μl IP dilution buffer and the DNA was sonicated.
A sample of the DNA was analysed by gel electrophoresis to ensure a fragment size of approxi-
mately 200–1000 base pairs. 40μl of washed Protein A bead slurry was added and rotated at
4°C for 1 hour. The beads were removed and the antibodies (and input containing no antibody)
were added and the sample was rotated over night at 4°C: β-catenin (Sigma C2206) 10μl; ETS
1/2 (Santa Cruz C-275) 25μl. 40μl of beads were added to each sample and the mix was incu-
bated for 1 hour at room temperature. The beads were washed and elution buffer was added
(150μl) to the beads and rotated for 15 minutes at room temperature. The elution step was
repeated once more. Thereafter the beads were discarded and 22.5μl 4M NaCl and 1μl RNase
A was added to the eluate and this was incubated 5 hours at 65°C. The sample was then precipi-
tated, the pellet was dissolved in and incubated with proteinase K at 45°C for 3 hours. After
Phenol/Chloroform extraction, the sample was precipitated again, and cleaned with the PCR
purification kit (Qiagen). It was eluted in 15μl TE buffer and stored at -20°C. For a detailed
protocol please contact the authors. Primer sequences are listed in S1 Table.
Quantification of in situ stainings
To quantify the staining, three independent sets (>10 fish each) were treated with DMSO,
SU5402, hsdnFGFR1 or hsFGF3 and processed identically for each experiment. These were
then scored for the presence of staining associated in the opercle, and the data was combined
to generate an average with associated standard deviation. As loss of staining was generally all
or nothing, animals were scored for the presence of any staining (scored as one) or the com-
plete loss of staining (scored as 0). The researcher was blind to which sample was control or
treated during this analysis.
FGF andWNT Regulate Osteoblast Differentiation
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Results
FGF signalling is required for ossification and the development of mature
osteoblasts
To determine whether FGF signalling acts during zebrafish bone development we took advan-
tage of a zebrafish transgenic line called hs:dnfgfr1 that expresses a dominant negative form of
the FGF under control of a heat shock promoter (Tg(hsp70l:dnfgfr1-EGFP); [52]). Hemizygous
fish were continuously exposed to dnFGFR1 from 48 hours post fertilisation (hpf) until 120hpf
(heat shock for one hr every eleven hours). This treatment completely abolished ossification
except for a small part of the cleithrum which begins to ossify before the start of the treatment
(Fig 1A and 1B). Chondrogenesis, which also takes place during this time period was not
noticeably affected (Fig 1C and 1D). It is possible that treatment starting at earlier timepoints
would affect the cartilagenous skeleton but such treatments result in disruption of morphogen-
esis of the embryo (data not shown). The loss of bone could reflect defects in calcium homeo-
stasis or in osteoblast activity. To determine whether osteoblasts were present and secreting
bone matrix proteins, we performed in situ analysis with opn, col10a1 and col1a2 (Fig 1E–1H
and data not shown). Although expression of col10a1 is typically described as being associated
with hypertrophic chondrocytes in mammals, it is expressed in mature osteoblasts in zebrafish
[43,53]. Both markers were drastically reduced or absent in treated fish suggesting that FGF
signalling is required for the differentiation or the anabolic activity of osteoblasts.
To test whether osteoblast differentiation requires FGF signalling we decided to analyse ear-
lier stages, focusing primarily on development of the opercle bone. runx2a and runx2b are
early markers of osteoblasts that first appear in the region of the opercle at around 48hpf fol-
lowed by osx at around 51hpf. We used the hs:dnfgfr1 line and the pharmacological inhibitor
SU5402 to block FGF signalling and a hs:fgf3 line to activate FGF signalling. To determine
when these treatments have their strongest effect, we used expression of pea3 (polyomavirus
enhancer activator 3) and erm (ets related molecule) as transcriptional read-outs of the FGF
pathway [54]. We found that three hours after the onset of treatment has the optimal effect on
FGF signalling throughout the embryo (S1 Fig). Treatment starting at 48hpf lasting for three
hours did not affect runx2a expression (Fig 2A–2D), and a mild reduction in runx2b was seen
only after treatment with SU5402 (Fig 2E–2H). In contrast, osx expression was strongly down-
regulated by both hs:dnfgfr1 and SU5402 treated fish and upregulated by hs:fgf3 (Fig 2I–2L). To
quantify these results we counted the number of fish which had staining in the opercle and did
qPCR on whole larvae and both methods established that perturbation of FGF signalling has a
significant effect on osx gene expression. To determine whether the expression of late osteo-
blast markers (i.e. bone matrix genes) is affected immediately following perturbation of FGF
signalling, we treated fish for three hours starting at 60hpf (S2 Fig). Neither SU5402 treatment
or hs:fgf3 had a an affect on the expression of col1a2 (and sparc, data not shown) indicating
that FGF signalling is not likely to directly regulate the expression of these bone matrix genes.
Wnt/β-Catenin signalling is required for ossification and the development
of mature osteoblasts
To determine the role of Wnt/β-Catenin signalling during osteoblast differentiation we used
two transgenic lines: hs:dkk1 (Tg(hsp70l:dkk1-GFP); [55]) to downregulate signalling and hs:
wnt8a (Tg(hsp70l:wnt8a-GFP); [56]) to upregulate signalling. We found that continuous sup-
pression of Wnt signalling starting at 48hpf resulted in reduced ossification levels at 120hpf
(Fig 3B). Similar treatment using hs:wnt8a resulted in an increase in ossification (Fig 3C). Nei-
ther treatment resulted in a strong change to the cartilagenous skeleton (Fig 3D–3F). It is
FGF andWNT Regulate Osteoblast Differentiation
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possible that treatment starting at earlier timepoints would affect the cartilagenous skeleton
but such treatments resulted in disruption of morphogenesis of the embryo (data not shown).
Treatment from 72hpf until 108hpf resulted in reduced col10a1 and col1a2 in hs:dkk1fish and
increased expression in hs:wnt8a fish (Fig 3G–3L). These data are comparable to the results
obtained by manipulating FGF signalling and suggest a role for Wnt/β-Catenin signalling in
osteoblast differentiation or bone matrix secretion.
To further investigate Wnt activity, we decided to test whether early markers of osteoblasto-
genesis are regulated by Wnt/β-Catenin signalling. We first assayed how rapidly the lines have
the predicted effect on knownWnt/β-Catenin targets. We found that 8 hours treatment
Fig 1. FGF signalling is required for ossification and osteoblast maturation. (A-D) Continuous inhibition
of FGF signalling from 48hpf to 120hpf in hs:dnfgfr1 larvae results in loss of ossification (B) but cartilage
formation is relatively unaffected (D). (E-H) Expression of mature osteoblast markers col1a2 and col10a1 is
severely reduced in hs:dnfgfr1 larvae (F,H). High magnification images of the opercle are shown to the right
of panels E-H. Abbreviations: bs = branchiostegal ray, cl = cleithrum, op = opercle. Scale bar = 200μM.
doi:10.1371/journal.pone.0144982.g001
FGF andWNT Regulate Osteoblast Differentiation
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starting at 48hpf has a strong effect on expression of both wif1 and axin2 (S3 Fig). Next we
looked at expression of runx2a, runx2b and osx and found that only osx expression was altered
by heatshock treatment (Fig 4A–4I). To validate this result we used qPCR to quantify the
reduction in osx expression after 12 hours of dkk1 over expression and found that expression is
reduced to 40% of wild type levels (Fig 4K). We also tested whether col1a2 expression responds
rapidly to Wnt/β-Catenin perturbation and found that it was unchanged (S2 Fig). Together
these results suggested that Wnt/β-Catenin signalling acts to promote osteoblast differentiation
and does so by activating osx expression.
FGF andWnt/β-Catenin signalling may activate osx expression via an
intronic cis-regulatory module
The activation of osx expression by FGF and Wnt/β-Catenin signalling is relatively rapid, sug-
gesting that it may be a direct target of these pathways. To further test this possibility, we per-
formed time courses to compare the kinetics of osx regulation to a known target gene. For FGF
Fig 2. FGF signalling regulates expression of osx. (A-H) Larvae were treated at 48hpf, fixed at 51hpf and expression of several bone markers was
analysed by in situ hybridisation. Arrowheads point to the opercle in the high magnification images to the right of each panel. Expression of runx2a (A-D) and
runx2b (E-H) is unchanged after inhibition of FGF signalling using hs:dnfgfr1 larvae as well as over activation in hs:fgf3 transgenic fish. Expression of runx2b
is slightly reduced after SU5402 treatment (F). (I-L) Expression of osx is decreased after inhibition of FGF signalling and increased after over activation of
FGF signalling as shown by in situ hybridization. Abbreviations: cl = cleithrum, op = opercle. Scale bar = 200μM. (M) Quantification for presence or absence
of osx staining in the opercle from I-L. Expression was normalised to the control. (N) qPCR performed in parallel to I-L confirm effects of FGF signalling on osx
expression. Treatments were normalised to gapdh. Treatment with SU5402 showed a significant reduction (p<0.05 Student's t-test).
doi:10.1371/journal.pone.0144982.g002
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signalling we treated embryos with SU5402 from 0 to 2 hours and tracked osx expression rela-
tive to that of pea3 (Fig 5A). For Wnt/β-Catenin signalling we compared osx to the TOP:GFP
transgene after over expression of dkk1 (Fig 5B). The TOP:GFP transgene contains a β-Catenin
responsive promoter that drives GFP expression [57]. In both situations osx down regulation
matched that of the known target gene, suggesting that osx is a transcriptional target of both
pathways.
We next used antibodies to β-Catenin to test whether conserved regions of the osx genomic
sequence (http://genome.ucsc.edu/) are enriched by ChIP (β-CatChIP). We tested three
Fig 3. Wnt/β-Catenin signalling regulates ossification and development of mature osteoblasts. (A-F) Continuous inhibition (hs:dkk1) or over activation
(hs:wnt8) of Wnt/β-Catenin signalling from 72-120hpf. Inhibition of Wnt/β-Catenin signalling results in reduced ossification as shown by Alizarin red staining
(B) whereas cartilage formation is largely unaffected (E). Overactivation of Wnt/β-Catenin signalling results in increased ossification and precocious
ossification of the hyomandibula (C). (G-L) Analysis of osteoblast markers after treatment from 72-108hpf. Expression of mature osteoblast markers col1a2
and col10a1 is slightly reduced whenWnt/β-Catenin signalling is inhibited (H,K) and enhanced by increasedWnt/β-Catenin signalling (I,L). Abbreviations:
hm = hyomandibula, op = opercle, te = teeth. Scale bar = 50μM.
doi:10.1371/journal.pone.0144982.g003
FGF andWNT Regulate Osteoblast Differentiation
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regions (approximate positions at -13600, -8250 and +97 in relation to the first start codon)
and based upon semi-quantitative PCR results (data not shown) focused on the conserved
region closest to the start codon. We designed 4 amplicons in this region and performed ChIP
with DNA from the hs:dkk1 and hs:wnt8a lines (Fig 5C and 5D and S4A Fig). We found that at
all locations, pull-down by β-Catenin was sensitive to dkk1 and wnt8a over expression (S4B
Fig). The most strongly enriched amplicon is at position +1146 and intriguingly this region is
close to a putative Runx2 binding site at +824 and is outside of the conserved region of intron 1
(Fig 5C).
The mitogen-activated kinase pathway is primarily activated by the FGF receptor in the
embryo, and Ets (v-ets erythroblastosis virus E26 oncogene homolog) transcription factors are
activated in response to the FGF/Mapk pathway [58–63]. Consistent with a role in osx regula-
tion, the Ets factors pea3, erm, ets1a and ets2 are all expressed in the region of the developing
skeleton at 54hpf (S1 and S5 Figs). To test whether Ets factors bind to osx intron 1, we took
advantage of a cross-reactive Ets1/2 antibody to do ChIP (EtsChIP). We found that as with β-
CatChIP, EtsChIP preferentially enriched the +1146 amplicon (Fig 5E). Furthermore enrich-
ment was slightly reduced in the presence of SU5402 suggesting that the ability of Ets1/2 to
bind this region is partly FGF dependent. The qPCR time course and ChIP experiments sup-
port the model that both FGF and Wnt/β-Catenin directly activate osx expression via a shared
intronic cis-regulatory module.
Crosstalk between the Wnt/β-Catenin and FGF pathway
Having established that both pathways are likely to act in parallel via intron 1, we wondered
whether there is any additional crosstalk between the two pathways which may modify osx
expression. We first performed epistasis to see whether FGF and Wnt/β-Catenin act sequen-
tially. We combined SU5402 and hs:wnt8a treatments and found that wnt8a activation of osx
expression is blocked by SU5402 and is therefore FGF dependent (Fig 6A–6D). This would
Fig 4. Wnt/β-Catenin signalling regulates osx expression. (A-I) Larvae were treated at 48hpf and fixed 12hours later. Expression of runx2a (A-C) and
runx2b (D-F) is unchanged after inhibition (hs:dkk1) or over activation (hs:wnt8) of Wnt/β-Catenin signalling. (G-L) Expression of osx is reduced in hs:dkk1
and increased in hs:wnt8 larvae 12 hours after the treatment. Arrowheads point to the opercle in the high magnification images to the right of each panel.
Abbreviations: cl = cleithrum. Scale bar = 50μM. (J) Quantification for presence or absence of osx staining in the opercle from G and H. Expression was
normalised to the control. (K) qPCR performed in parallel on g and h confirms the effects of Wnt/β-Catenin signalling on osx expression (p<0.01 using
Student's t-test). Treatments were normalised to gapdh.
doi:10.1371/journal.pone.0144982.g004
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Fig 5. osx is likely to be a direct target of FGF andWnt/β-Catenin signalling. (A) Down regulation of osx and pea3 by SU5402 show the same kinetics as
monitored by qPCR over a two hour period. (B) Down regulation of osx and TOP:GFP in hs:dkk1 fish shows the same kinetics as monitored by qPCR over a
six hour period. (C) A diagram of the osx gene centred on the first start codon in exon 1 (white box). Light blue shading shows conservation between
zebrafish and medaka genomic sequence (http://genome.ucsc.edu/). Putative Lef/Tcf, Ets1/2 and Runx2 binding sites are indicated above. The amplicons
used for ChIP analysis are indicated below, the numbers represent the approximate centre of the amplicon in relation to the start. (D, E) β-Catenin (at 53hpf)
FGF andWNT Regulate Osteoblast Differentiation
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suggest that FGF acts downstream of Wnt/β-Catenin signalling. However, when we combined
hs:dkk1with hs:fgf3 we found that fgf3 activation of osx is dependent upon Wnt/β-Catenin sig-
nalling (Fig 6E–6H). Together these data indicates that neither pathway is sufficient to induce
osx expression on its own. One model to explain these results is that ETS factors and β-Catenin
interact in the nucleus to form a complex on the osx gene.
We next checked to see whether Wnt/β-Catenin affects activity of the FGF pathway and
vice versa. We found that wnt8a over expression upregulates components of the FGF pathway
while dkk1 downregulates the same components (Fig 6I–6T). As many components of the FGF
pathway are themselves regulated by FGF signalling (through negative feed back), it is difficult
to say conclusively that Wnt/β-Catenin is having a positive affect on the pathway as a whole.
However, given the timing of the experiments it seems likely that that Wnt/β-Catenin signal-
ling has the capacity to indirectly influence osx expression by increasing FGF activity. To test
whether a reciprocal interaction takes place, we tested whether expression of components of
and Ets1/2 (at 53hpf) preferentially bind to osx genomic sequences when compared to the unrelated gene her9. The input bar is the ratio of her9 amplicon to
osx amplicon before antibody pull down and the ChIP bar is that ratio after pull down. For normalisation, the input ratio of her9 to osx amplicon is set to 1.
Panel E also shows ChIP from fish treated from 51-53hpf with SU5402 which have a mild reduction in Ets1/2 binding activity. p<0.015 for β-CatChIP at
osx1146 and p<0.001 for EtsChIP at osx1146.
doi:10.1371/journal.pone.0144982.g005
Fig 6. FGF andWnt/β-Catenin signalling interact to regulate osteoblast differentiation. (A-D) Larvae were heat shocked at 48hpf, treated with SU5402
at 50hpf and fixed at 52hpf. Expression of osx is reduced after SU5402 (C) treatment and increased in hs:wnt8 larvae (B). Combined SU5402 and hs:wnt8
treatment still results in reduced expression of osx (D). (E-H) Larvae were heat shocked at 49hpf and fixed at 52hpf. Expression of osx is reduced in hs:dkk1
larvae (F) and increased in hs:fgf3 larvae (G). Expression is reduced in the combined treatment (H). (I-T) fgf3, sprouty1, sprouty4 and sef expression is
inhibited by dkk1 over expression (K, N, Q, T) and activated by over expression ofwnt8 (J, M, P, S). Arrowheads point to the opercle in the high magnification
images to the right of each panel. Scale bars = 200μM.
doi:10.1371/journal.pone.0144982.g006
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the Wnt/β-Catenin pathway are affected by SU5402 treatment, hs:fgf3 or hs:dnfgfr1 treatment
(S6 Fig). None of these treatments altered expression of wif, axin2, lef1 or tcf7 suggesting that
FGF signalling does not modulate the activity of the Wnt/β-Catenin pathway in this context.
Discussion
Specification of the osteoblast fate choice in mesenchymal stem cells is a multistep process
which involves several developmental signalling pathways. Here we investigate this process in
the developing facial skeleton and show that both the FGF and Wnt/β-Catenin pathways act
on osteoblast precursors to promote bone formation. We have found that manipulation of
both pathways has an immediate and strong effect on osx expression while having a lesser effect
on runx2 and bone matrix genes. These finding suggest that these pathways both act predomi-
nantly at an intermediate level of osteoblast specification after recruitment to the osteoblast
lineage. We show that FGF andWnt/β-Catenin dependant expression of osx has the same
kinetics as that of known read-outs suggesting that osx is a direct target of both pathways. To
identify the precise mechanism of action, we have performed ChIP experiments and identified
a region of the osx first intron that is bound by β-Catenin and ETS1/2 in pull down experi-
ments. Thus we have demonstrated that both pathways are likely to interact at the level of osx
gene transcription to modulate osteoblast differentiation in vivo (Fig 7). In addition to this
interaction on the DNA, we have also found that there is a second potential level of regulation
by which the Wnt/β-Catenin pathway acts to modulate activity of the FGF pathway during
facial skeletal development.
Many studies on the roles of these pathways in skeletogenesis have not yet revealed a clear
picture of how they interact to coordinate osteoblast differentiation. These conflicting results
may be explained in part by complex feedback loops and redundancies that may obscure
results. Our study aimed to identify the earliest responses to signalling perturbation to help to
tease apart these interactions and give a clearer picture of the direct effects of these pathways.
Fig 7. A model for how interactions between FGF andWnt/β-Catenin signalling pathways interact to
regulate osx transcription.
doi:10.1371/journal.pone.0144982.g007
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We have also utilised an in vivo system to avoid artefacts that are inherent in cell-based studies.
One surprising outcome of our study is the relatively weak influence that the Wnt/β-Catenin
and FGF pathways exert on runx2a/b expression. A consensus of studies in mammals have
shown that both pathways activate runx2 both in vivo and in vitro (reviewed in [64]). This dif-
ference may be because our study focuses upon the head skeleton which is primarily neural
crest derived, or may indicate a more fundamental difference between zebrafish and mamma-
lian osteoblast differentiation.
One fundamental question in skeletal biology is how signalling pathways regulate the mor-
phogenesis of bones in the early embryo. One recent study showed that indian hedgehog a
(ihha) drives proliferation of cells surrounding the distal edge of the opercle and in ihha
mutants morphogenesis of the opercle is disrupted[65]. Consistent with this role for Hedgehog
signalling, another study has shown that ectopic bone forms on the opercle in patched1
mutants in which Hedgehog signalling is elevated[66]. Intriguingly, neither study found that
Hedgehog signalling regulates expression of runx2a, runx2b or osx during opercle osteoblasto-
genesis suggesting that ihhamay act downstream of the Wnt/β-Catenin and FGF pathways. In
the future, it will be interesting to identify which FGF andWnt ligands are expressed around
the opercle during this time and to determine how their activity is coordinated with that of
ihha to the shape the opercle.
Supporting Information
S1 Fig. Inhibition and over activation of FGF signalling have optimal effects 3 hours after
the treatment. (A-H) Inhibition of FGF signalling, using SU5402 treatment or hs:dnfgfr1 larvae
resulted in strong down regulation of pea3 and erm expression 3 hours after the treatment (B,
C, F, G). Over activation of FGF signalling in hs:fgf3 larvae resulted in strong upregulation of
pea3 and erm after 3 hours (D, H). (I-P) 6 hours after the treatment, inhibition of FGF signal-
ling still resulted in slight down regulation of pea3 and erm expression (J, K, N, O) whereas
expression was unchanged in hs:fgf3 larvae (L, P). Scale bar = 200μM.
(PDF)
S2 Fig. Neither FGF nor Wnt signalling affect col1a2 expression. (A-C) Larvae were treated
at 60hpf and fixed 3 hours later. Expression of col1a2 is unaffected 3 hours after inhibition
(SU5402) or over activation (hs:fgf3) of FGF signalling. (D-F) Larvae were treated at 60hpf and
fixed 12 hours later. Inhibition (hs:dkk1) or over activation (hs:wnt8) of Wnt/β-Catenin signal-
ling also does not affect expression of col1a2. Arrowheads point to the opercle in the high mag-
nification images to the right of each panel. Abbreviations: cl = cleithrum. Scale bar in
F = 200μM.
(PDF)
S3 Fig. Wnt/β-Catenin signalling regulates wif1 and axin2 expression. (A-P) Larvae were
treated from 48hpf to 56hpf. Expression of the knownWnt/β-Catenin targets wif1 and axin2 is
strongly reduced 8 hours after inhibition (hs:dkk1; D, H, L, P) or increased after over activation
(hs:wnt8; B, F, J, N) of Wnt/β-Catenin signalling.
(PDF)
S4 Fig. β-CatChIP preferentially enriches for the +1146 amplicon and is sensitive to Wnt/
β-Catenin signalling. β-CatChIP was performed in hs:dkk1 and hs:wnt8 lines heat shocked at
48hpf then fixed at 54hpf and 60hpf respectively. The ratio of the control amplicon her9 to the
osx amplicon in the input was used to normalise the levels after ChIP. (A) Shows that -962,
+896 and +1146 all show enrichment after ChIP with +1146 being the highest. (B) β-CatChIP
is sensitive to Wnt/β-Catenin signalling. Transgenic ChIP is compared directly to sibling ChIP
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to show that there is on average a 20% reduction in pull down efficiency in hs:dkk1 fish and a
1.5 fold increase in efficiency in hs:wnt8 fish.
(PDF)
S5 Fig. Expression of the Ets factors elk1, ets1a and ets2. (A-C) All three factors are expressed
in regions around the developing bone at 54hpf, with ets1a and ets2 showing the highest
expression.
(PDF)
S6 Fig. Expression of Wnt/β-Catenin target genes is unaffected by FGF signalling. (A-P)
Larvae were heat shocked or treated with SU5402 at 48hpf and fixed at 51hpf. Expression of
wif, axin2, lef1 and tcf7 is unaffected by inhibition (hs:dnfgfr1) or over activation (hs:fgf3) of
FGF signalling. Scale bar = 200μM.
(PDF)
S1 Table. Sequences of primers used in this study.
(DOCX)
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